Guardant Health (GH) Tops Q3 EPS by 30c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mail
Get Alerts GH Hot Sheet
Join SI Premium – FREE
Guardant Health (NASDAQ: GH) reported Q3 EPS of ($0.67), $0.30 better than the analyst estimate of ($0.97). Revenue for the quarter came in at $143 million versus the consensus estimate of $137.35 million.
For earnings history and earnings-related data on Guardant Health (GH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Roth/MKM Starts Guardant Health (GH) at Buy
- Meta's capital-raising plans expose a major weakness in the AI boom
- AI chip sell-off is ‘unmoored from fundamentals,’ LYNX says
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
